Press Releases

ToxExpo keeps members and attendees up-to-date on the latest news with Press Release postings. This complimentary service is available to all exhibiting companies.

  • 8 March 2016 - Today Toxys and Mitologics announce a strategic partnership to jointly offer their unique in vitro toxicity assays. The ever-increasing number of chemical compounds as well as nanomaterials that are developed by industry poses a potential threat for human health. These compounds and materials may react with various... Learn More

  • “Comprehensive Toxicology and Pharmacogenomics Test Automation Within a Single LIMS Platform” New Orleans (March 14, 2016) –  For toxicology laboratories adding genomic analyses, UNIConnect, the specialist in laboratory process management software for molecular testing, will introduce their newest LIMS offering, pMDx-TOX, at the Society of Toxicology’s 55th Annual Meeting and ToxExpo,... Learn More

  • In booth 927, Camino Information Services is proudly announcing the full relase of ToxFusion, a cloud based order entry and results portal designed specifically for the toxicology industry. Stop by the booth for a demo of this affordable product. ... Learn More

  • Submitted on: Mar 03, 2016, by Seventh Wave (#960)

    Wave of the Future: Seventh Wave Laboratories Purchases Building for Expansion, Upcoming Move FOR IMMEDIATE RELEASE May 21, 2015 Expansion project will allow for additional offices, laboratory space, and new jobs to accommodate a growing client base and additional service lines St. Louis, MO—Seventh Wave Laboratories, a consulting-based contract research organization that assesses the... Learn More

  • Lincolnshire, Ill. (Mar. 1, 2016) Sysmex America, Inc. today announced that it will exhibit its research laboratory solutions at the Society of Toxicology’s annual ToxExpo show March 13-17 at the Ernest N. Morial Convention Center in New Orleans, La. Offerings will include Sysmex’s broad range of flow cytometry products as... Learn More

  • US EPA has accepted our studies including EDSP Tier-I, DART, Immunotoxicity and Neurotoxicity studies As part of a recent regulatory submission (June 2015) a number of JRF studies were reviewed and classified as 'Acceptable: - Guideline' by US EPA. The US EPA issued Draft Human Health Risk Assessment for a certain product... Learn More

  • Founded in 1996 by Dr. FX. Bernard & Dr. A. Deguercy, BIOalternatives is a research service provider specialized in cellular and molecular pharmacology. BIOalternatives provides services to support the early stages of drug discovery and the claim substantiation of healthcare products (active ingredients and finish products) using up-to-date in vitro solutions. Our capabilities include fast and cost-effective... Learn More

  • BEIJING--(BUSINESS WIRE)--Pharmaron, a fully integrated contract research organization (CRO) offering laboratory and manufacturing services for pharmaceutical and biotech research and development, today announced that it acquired Quotient Bioresearch (Quotient). Quotient, a UK-based CRO with more than 200 employees, focuses on integrating radiochemistry and metabolism. Part of this expertise is derived... Learn More